Cargando…
Far Beyond Cancer Immunotherapy: Reversion of Multi-Malignant Phenotypes of Immunotherapeutic-Resistant Cancer by Targeting the NANOG Signaling Axis
Cancer immunotherapy, in the form of vaccination, adoptive cellular transfer, or immune checkpoint inhibitors, has emerged as a promising practice within the field of oncology. However, despite the developing field's potential to revolutionize cancer treatment, the presence of immunotherapeutic...
Autores principales: | Oh, Se Jin, Lee, Jaeyoon, Kim, Yukang, Song, Kwon-Ho, Cho, Eunho, Kim, Minsung, Jung, Heejae, Kim, Tae Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049583/ https://www.ncbi.nlm.nih.gov/pubmed/32158595 http://dx.doi.org/10.4110/in.2020.20.e7 |
Ejemplares similares
-
Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle
por: Oh, Se Jin, et al.
Publicado: (2022) -
NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59
por: Son, Sung Wook, et al.
Publicado: (2022) -
API5 confers cancer stem cell-like properties through the FGF2-NANOG axis
por: Song, K-H, et al.
Publicado: (2017) -
Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators
por: Debele, Tilahun Ayane, et al.
Publicado: (2020) -
Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023)